Transactions
Westcove Advises Clinical Research of West Florida in its Partnership with Fengate Private Equity
October 2026
Client: Clinical Research of West Florida (“CRWF”) is a leading independent clinical research platform operating three Phase I–IV facilities across the Tampa Bay area. Founded in 1995, CRWF has conducted 1,000+ trials across a broad range of therapeutic areas, with differentiated expertise in complex autoimmune and rheumatology indications. The Company’s experienced investigator base, proprietary patient database, and preferred relationships with leading sponsors and CROs have established CRWF as a trusted partner for high-quality trial execution and patient enrollment.
“Westcove was unquestionably the right partner for us. Their understanding of our business and the clinical research industry as a whole, was evident throughout the process. From the outset, we felt they always had our back and were fully invested in achieving the best outcome for our company and team. Most importantly, they recognized the value of the organization we had built and what mattered most to us in a partner. We are very excited to partner with Fengate and continue building CRWF into a leading clinical research platform.”
– Aydin Keskiner, Owner and President, Clinical Research of West Florida
Role: Westcove Partners acted as the exclusive financial advisor to Clinical Research of West Florida in its partnership with Fengate Private Equity, a division of Fengate Asset Management.
Location: Tampa, FL
Sector: Pharmaceutical Services, Clinical Research
Transaction Team
Geno Catalano
Vice President
Andrew Hartono
Associate
